David Marriott, a distinguished litigator, is renowned for his experience handling high-stakes disputes across federal and state courts and administrative agencies.
A recognized leader, David is a fellow of the American College of Trial Lawyers and the International Academy of Trial Lawyers. He also routinely receives accolades from the legal press for successfully representing clients in precedent-setting matters.
David leverages his trial skills and strategic acumen to guide clients in business-defining litigation involving:
David advises across a broad range of highly scrutinized industries, including technology, healthcare, pharmaceuticals, consumer products, and telecommunications.
In addition to his practice, David is an Adjunct Professor at New York University School of Law and a Lecturer in Law at Columbia University School of Law, where he teaches antitrust, intellectual property, and trial practice.
Before joining Latham, David was a partner at another leading law firm.
A Latham litigation team secured dismissal with prejudice of an antitrust class action challenging Novartis’ listing of Entresto-related patents in the FDA’s Orange Book.
Two Latham teams recognized for securing a trial win at the ITC for Estelgia, LLC and Netgear over Wi-Fi technology as well as an antitrust win for Eli Lilly involving GLP-1 medications.
Sy Damle, Gabe Fleet, Andy Gass, Britt Lovejoy, David Marriott, Al Pfeiffer, Alli Stillman, Jonathan West, and Joe Wetzel recognized as leaders in the music industry.